BioCentury | Apr 23, 2012
Company News

Serametrix Corp., Penn State Hershey Children's Hospital deal

...of stem cell therapies in children with relapsed neuroblastoma and sarcoma. Over the next year, Serametrix...
...company's panel of cancer antigens from patients enrolled in the trials. Details were not disclosed. Serametrix Corp....
BioCentury | Nov 21, 2011
Company News

OncoSec, Serametrix Corp. deal

...MCC) and malignant melanoma. Terms were not disclosed. OncoSec Medical Inc. (OTCBB:ONCS), San Diego, Calif. Serametrix Corp....
BioCentury | Apr 26, 2010
Company News

Serametrix Corp. sales and marketing update

...Research (New York, N.Y.) to patents covering NY-ESO-1 last year (see BioCentury, Oct. 19, 2009). Serametrix Corp....
BioCentury | Oct 19, 2009
Company News

Serametrix Corp., Ludwig Institute for Cancer Research deal

...to the institute's patents covering tumor antigen NY-ESO-1. The partners will use the IP and Serametrix's...
...patients. The Institute will receive an equity stake in Serametrix. Financial terms were not disclosed. Serametrix Corp....
Items per page:
1 - 4 of 4
BioCentury | Apr 23, 2012
Company News

Serametrix Corp., Penn State Hershey Children's Hospital deal

...of stem cell therapies in children with relapsed neuroblastoma and sarcoma. Over the next year, Serametrix...
...company's panel of cancer antigens from patients enrolled in the trials. Details were not disclosed. Serametrix Corp....
BioCentury | Nov 21, 2011
Company News

OncoSec, Serametrix Corp. deal

...MCC) and malignant melanoma. Terms were not disclosed. OncoSec Medical Inc. (OTCBB:ONCS), San Diego, Calif. Serametrix Corp....
BioCentury | Apr 26, 2010
Company News

Serametrix Corp. sales and marketing update

...Research (New York, N.Y.) to patents covering NY-ESO-1 last year (see BioCentury, Oct. 19, 2009). Serametrix Corp....
BioCentury | Oct 19, 2009
Company News

Serametrix Corp., Ludwig Institute for Cancer Research deal

...to the institute's patents covering tumor antigen NY-ESO-1. The partners will use the IP and Serametrix's...
...patients. The Institute will receive an equity stake in Serametrix. Financial terms were not disclosed. Serametrix Corp....
Items per page:
1 - 4 of 4